Study of Rasburicase as Treatment or Prevention of Hyperuricemia Associated With Tumor Lysis Syndrome in Patients With Relapsed or Refractory Lymphoma, Leukemia, or Solid Tumor Malignancy
Clinical trial NCT00230217 · COMPLETED
Trial details
- NCT number
- NCT00230217
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2004-03-01
- Primary completion
- 2006-07-01
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.